A man undergoing hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide can be used safely and effectively for patients with APL under hemodialysis.
Keywords: acute promyelocytic leukemia; arsenic trioxide; chronic kidney disease.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.